A Longitudinal Study of Neuromyelitis Optica and Transverse Myelitis
This study seeks to determine the biologic causes of inflammation in patients with Neuromyelitis Optica (NMO) and related conditions. While patients will be treated according to decisions with their treating physician, this study will collect data and samples from patients prospectively to gain a better understanding of the disease. We are seeking to understand why some patients respond to medications, while others do not. We also seek to understand what happens biologically, preceding relapses. Gathering these data and samples will allow researchers to identify new ways of diagnosing and treating these diseases. Data and samples will be shared with researchers around the world to support collaborative efforts to treat these conditions.
Neuromyelitis Optica Spectrum Disorder
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||A Longitudinal Study of Patients Diagnosed With or at Increased Risk for Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder|
Patients will donate serum, plasma, DNA, RNA and white blood cells.
|Study Start Date:||June 2012|
|Estimated Primary Completion Date:||June 2017 (Final data collection date for primary outcome measure)|
|Neuromyelitis Optica Spectrum Disorder|
Transverse Myelitis and Optic Neuritis
Patients who have had one demyelinating event, not diagnosed with multiple sclerosis and whom are considered at risk for NMO or NMOSD.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01623076
|Contact: Dina Obrien, BA||214-645-7977||Dina.email@example.com|
|Contact: Samuel Hughes, BS||214-645-0561||Samuel.Hughes@utsouthwestern.edu|
|United States, Texas|
|The University of Texas Southwestern Medical Center||Recruiting|
|Dallas, Texas, United States, 75390|
|Principal Investigator: Benjamin M Greenberg, MD, MHS|